Pre-Clinical Imaging (In-vivo) Market – Global Industry Analysis, Size and Future Scope

Pre-Clinical Imaging MarketThe global pre-clinical imaging (in-vivo) market is growing significantly due to development of high resolution and sensitive imaging devices with various applications in the industry. Massive unexplored market in pre-clinical imaging (in-vivo) industry of developing economies are creating ample opportunities for the pre clinical imaging market to grow at a considerable rate in the coming years. Further, technological advancement in pre-clinical imaging will support the growth of the global pre-clinical imaging (in-vivo) market in the coming years.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/pre-clinical-imaging-market/report-sample

Pre-clinical (in-vivo) imaging is bridging a gap between the vivo clinical research and vitro exploratory. It is increasingly being deployed across the drug development process, specifically in oncology therapeutic area. The advanced research and development facilities and new product developments of the companies are supporting the growth of pre-clinical imaging (in-vivo) industry. Moreover, integration of pre-clinical MRI systems with other imaging modalities is also expected to propel the growth of the global pre-clinical imaging market in coming years.

On the basis of type of modalities of pre-clinical imaging (in-vivo), the market can be categorized as optical imaging systems, pre-clinical nuclear imaging systems, micro-magnetic resonance imaging (MRI), micro-ultrasound, micro-CT, pre-clinical photoacoustic imaging system, pre-clinical magnetic particle imaging system and others. The optical imaging system lead the pre-clinical imaging (in-vivo) market, by type of modalities category; whereas, the pre-clinical nuclear imaging system segment is expected to grow with the fastest rate in the coming years due to rising adoption of pre-clinical imaging and development of technologically hybrid nuclear imaging systems.

Explore Report at: https://www.psmarketresearch.com/market-analysis/pre-clinical-imaging-market

Some of the companies operating in the pre-clinical imaging (in-vivo) market are Perkinelmer Inc., Mr Solutions Ltd., Mediso Ltd., Bruker Corporation, Trifoil Imaging, Fujifilm Visualsonics Inc., Biospace Lab S.A., Milabs B.V., Li-Cor Biosciences, Thermo Fisher Scientific, Agilent Technologies and Aspect Imaging.

 

Advertisements

Ophthalmology Devices Market Analysis, Drivers, Trends, Challenges and Demand, 2023

Ophthalmology Devices Market

The global ophthalmology devices market is growing significantly due to increasing prevalence of eye diseases, and technological advancements in ophthalmic devices. Shortages of ophthalmology devices providers in emerging economies and increasing age-related eye diseases are creating ample opportunities for the ophthalmology devices market to grow at a considerable rate in the coming years. The advanced research and development facilities and new product developments by the companies are propelling the demand for cost effective ophthalmic devices.

Explore Report at: https://www.psmarketresearch.com/market-analysis/ophthalmology-devices-market

The ophthalmology devices market is segmented on the basis of therapeutic applications, end-users, and products type. Based on therapeutic applications, the ophthalmology devices market can be categorized as diabetes retinopathy, cataract, macular degeneration, glaucoma, and others. Cataract leads the ophthalmology devices market due to high prevalence of cataract worldwide. Based on end-user, the ophthalmology devices market can be segmented as academic institutes and research laboratories, hospitals and others.

On the basis of products type, the ophthalmology devices market can be categorized as vision care devices, diagnostic devices, and surgical devices. The diagnostic devices segment includes optical coherence tomography (OCT) scanners, ophthalmic ultrasound imaging systems, fundus camera, retinoscopes and ophthalmoscopes, corneal topographers, visual field analyzers, tonometers, slit lamps, specular microscope, wavefront aberrometers, autorefractors, biometer, optotype projectors, and others. The surgical devices segment includes vitreoretinal surgery devices, cataract surgery devices, glaucoma surgery devices, and refractive surgery devices. Whereas, vision care devices segment includes spectacle lenses and contact lenses. Vision care devices segment is expected to grow with the fastest rate in the coming years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/ophthalmology-devices-market/report-sample

Some of the major players operating in the global ophthalmology devices market are Alcon Inc., Bausch & Lomb Inc., Abbott Medical Optics, Topcon Corporation, Carl Zeiss Meditec AG, Haag Streit, Johnson & Johnson, Nidek Co. Ltd., STAAR Surgicals, Hoya Corporation, Essilor International S.A., and Zeimer Ophthalmic Systems AG among others.

Veterinary Diagnostics Market – Analysis, Size, Growth and Demand, 2023

Veterinary Diagnostics MarketThe global veterinary diagnostics market is growing significantly due rising requirement for combat antimicrobial-resistant bacteria, increasing awareness of animal health in emerging economies, and growing investment in developing economies in the industry. Increasing number of new and technologically advanced products in veterinary diagnostics market is creating sufficient opportunity for the veterinary diagnostics market to grow at a substantial rate in the forecasted period. In addition, massive unexplored market in veterinary diagnostics industry of developing economies are creating ample opportunities for the veterinary diagnostics market to grow at a considerable rate in the coming years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/veterinary-diagnostics-market/report-sample

The advanced research and development facilities, and new and innovative product developments by the companies to improve their product portfolio are propelling the growth of the veterinary diagnostics industry. Mounting usage of nanotechnology in veterinary diagnostics, modification of human diagnostic application into veterinary diagnostics, and increasing demand for precise, and quick molecular diagnosis are some of the major trends of the global veterinary diagnostic market.

On the basis of type of animal, the veterinary diagnostics market is segmented as companion animals and food producing animals. The companion animals segment includes dogs, horses and cats. The food producing animals include pigs, cattle, poultry, and others. Moreover, on the basis of end users, the veterinary diagnostics market is segmented into veterinary hospitals and clinics, research institutions, point-of-care testing, and others.

Explore Report at: https://www.psmarketresearch.com/market-analysis/veterinary-diagnostics-market

Geographically, North America will be leading the global veterinary diagnostics market in the coming years, due to increasing awareness of animal health and increasing ability of veterinarians to provide animal diagnostics services. Asia-Pacific is the fastest growing region in the global vaccine market. The major reasons for the fastest growth of veterinary diagnostics market in the region are rising number of companion animals due to mounting urbanization, and rise in per-capita income, in the region. Moreover, the veterinary diagnostics market is growing due to increasing awareness of animal health in the emerging countries, such as India and China, of Asia-Pacific region.

Some of the companies operating in the global veterinary diagnostics market are IDEXX Laboratories, Inc., Virbac SA, Zoetis, Inc., Thermo Fisher Scientific, Inc., ABAXIS, Inc., Virbac SA, Neogen Corporation, VCA Antech, Inc., HESKA Corporation, and Mindray Medical International, Ltd.

Neuromodulation Devices Contribute Largest Revenue to Global Nerve Repair and Regeneration Market

Nerve Repair and Regeneration Market Size

The global nerve repair and regeneration market is likely to grow significantly during the forecast period, due to increasing geriatric population, rising prevalence of chronic pain and increasing incidence of neurological disorders. In addition, the awareness about mental diseases and their treatment and technological advancement in nerve repair and regeneration products is also increasing globally, which contributes to the growth of the market. Lack of skilled professionals, high cost and side effects associated with the usage of neurostimulation and neuromodulation devices are the key factors restraining the global market growth.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/nerve-repair-and-regeneration-market/report-sample

North America has been the largest market for nerve repair and regeneration, with the U.S. being the largest contributor to the regional market. Increasing incidence of peripheral nerve injuries and presence of technological advanced products has been driving the growth of the North American market. In Europe, Germany has been the largest contributor to the nerve repair and regeneration market, followed by the U.K. and France. The market is expected to witness highest growth in Asia-Pacific, during 2017 – 2023, owing to increasing cases of neurological disorders and increasing geriatric population.

Globally, the aging population plays a key role in the growth of the nerve repair and regeneration market. The elderly people are more susceptible to suffering from chronic pain and neurological disorders, such as Alzheimer’s, epilepsy and Parkinson’s as compared to adults. According to the United Nations Department of Economic and Social Affairs (UN-DESA) report, the number of people aged 60 years or over is projected to grow by 56.0%, globally, i.e. from 901 million in 2015 to 1.4 billion by 2030. Also, by 2050, the global aging population is projected to reach nearly 2.1 billion in number. Additionally, the number of people aged 60 years and above is expected to reach approximately 437 million in China, 324 million in India, 107 million in the U.S. and 58 million in Brazil by 2050.

Explore Report at: https://www.psmarketresearch.com/market-analysis/nerve-repair-and-regeneration-market

Some of the key players in the global nerve repair and regeneration market include Boston Scientific Corporation, Axogen, Inc., Cyberonics, Inc., Medtronic, PLC, Baxter International Inc., St. Jude Medical, Inc., Integra Lifesciences Holdings Corporation, Inc., Stryker Corporation, Orthomed S.A.S. and Polyganics B.V.

Tissue Diagnostics Market 2023 – Drivers, Restraints, Opportunities and Challenges

Tissue Diagnostics Market

The global tissue diagnostics market is growing significantly due to increasing prevalence of cancer, and technological advancements in tissue diagnostics. Massive unexplored tissue diagnostics market in emerging economies and lack of efficient diagnostic procedures are creating ample opportunities for the global tissue diagnostics market to grow at a considerable rate in the coming years. The advanced research and development facilities and increasing investment by large pharmaceutical companies in small tissue diagnostics companies are propelling the demand for cost effective and efficient tissue diagnostics instruments.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/tissue-diagnostics-market/report-sample

A recent trend observed in thetissue diagnostics industry is increasing usage of immunohistochemistry products as companion diagnostics devices. Increasing prevalence of cancer has fuelled the demand of better diagnostic techniques, which could detect cancer in the earliest stage. According to the WHO, in 2012, there were 14 million new cancer cases and 8.2 million cancer related deaths worldwide.

The global tissue diagnostics market is categorized on the basis of product type, technology, application, and end-user. Based on product type, the tissue diagnostics market can be categorized as instruments and consumables. On the basis of technology, the tissue diagnostics market is categorized as digital pathology and workflow management, in situ hybridization, immunohistochemistry, and special staining. The immunohistochemistry segment leads the global tissue diagnostics market in terms of market size.

Explore Report at: https://www.psmarketresearch.com/market-analysis/tissue-diagnostics-market

Geographically, North America will be leading the global tissue diagnostics market in the coming years due to high prevalence of cancer cases, high healthcare expenditure, and presence of a large number of hospitals and pharmaceutical companies. Additionally, the legislative reform of Affordable Care Act in the U.S. is also expected to drive the North American market in the coming years. Asia-Pacific is the fastest growing region in the global tissue diagnostics market. The major reasons for the fastest growth in the region are aging population, increasing disposable income, and improving healthcare infrastructure. Moreover, the tissue diagnostics marketis growing due to large unexplored tissue diagnostics market and large population base suffering with cancer in the emerging economies, such as India and China, of Asia-Pacific region.

Some of the major players operating in the global tissue diagnostics market are F. Hoffmann-La Roche AG., Sigma Aldrich Corporation, Abbott, Biogenex Laboratories, BioSB, Cell Signalling Technology Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, GE Healthcare, and Siemens Healthcare.

Audiological Devices Market Size, Analysis, Growth and Demand, 2023

The global audiological devices market is growing significantly due to introduction of waterproof and wireless hearing aids, increasing need for aesthetically fabricated hearing aids, and increasing government initiatives to provide better healthcare services in the industry. Massive unexplored market in audiological devices industry of developing economies are creating ample opportunities for the audiological devices market to grow at a considerable rate during the forecasted years.In addition, increasing adoption of digital technology in developing and designing hearing aid is also expected to support the growth of the market in the coming years. Further, the advanced research and development facilities, and new and innovative product developments by the companies are propelling the growth of the audiological devices industry.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/audiological-devices-market/report-sample

Audiological Devices Market

Hearing impairment is usually due to genetic predisposition and chronic ear infection. Increasing prevalence of hearing problems is also fueling the growth of the market in the coming years. According to World Health Organization, globally approximately 360 million people were disabled with hearing loss in 2012. Audiological devices are hearing aids used for the diagnosis and treatment of hearing impairment and balance problems. An audiological device comprises microphone, speaker and amplifiers.

On the basis of product type of audiological devices, the market can be categorized as hearing aids, diagnostic devices, bone anchored hearing aids, and cochlear implants. Hearing aids lead the market in terms of market size, as it is user friendly and comfortable; whereas, cochlear implants are expected to grow at a faster rate in the coming years due to technological advancement.

Explore Report at: https://www.psmarketresearch.com/market-analysis/audiological-devices-market

Geographically, Europewill be leading the global audiological devices market in the coming years, due to propitious reimbursement policies, increasing government support and introduction of innovative products. Asia-Pacific is the fastest growing region in the global audiological devices market. The major reasons for the fastest growth of audiological devices market in the region are increasing healthcare expenditure, large pool of patients, increasing government support, improving healthcare infrastructure, and increasing incidence of deafness in the region. Moreover, the audiological devices market is growing due to increasing awareness of healthcare in the emerging countries, such as India and China, of Asia-Pacific region.

Some of the companies operating in the global audiological devices market are Siemens Healthcare, Cochlear Limited, Widex A/S, Bernafon, Sonova Holdings AG, SeboTek Haring Systems, GN ReSound Group, William Demant Holding A/S, Beltone, and Starkey Hearing Technologies.

Auto-Injectors Market Analysis, Drivers, Growth Rate, Specifications & Forecast

Auto-Injectors Market

The global auto-injectors market is likely to grow significantly during the forecast period, due to increasing prevalence of anaphylaxis, increasing cases with multiple sclerosis, rising geriatric population and high production of biologics. Additionally, increasing healthcare spending and various beneficial features of auto-injectors also contribute to the growth of the overall market. However, high cost of auto-injectors and stringent regulatory requirements are some of the key factors restraining the growth of global auto-injectors market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/auto-injectors-market/report-sample

The prefilled auto-injectors is the larger product category in the global auto-injectors market, primarily due to increasing availability of user friendly prefilled auto-injectors in disposable form. Based on manufacturing design, standardized auto-injector was the larger contributor to the global auto-injectors market in comparison to customized auto-injector in 2016. Anaphylaxis was the largest application for auto-injectors, followed by multiple sclerosis, rheumatoid arthritis and other diseases, in 2016. According to World Allergy Organization (WAO), the prevalence of anaphylaxis ranged from 2% of the population in the US, to 0.1% of the population in Korea, and 0.6% to 1% of the population in Australia.

Globally, the increasing demand for biologics has been playing a key role in the growth of the auto-injectors market. The rapidly increasing burden of anaphylaxis, multiple sclerosis, rheumatoid arthritis and other diseases further compels government organizations and healthcare providers to provide improved facilities for effective disease treatment, leading to rising number of launches of technologically advanced products, globally.

Explore Report Description at: https://www.psmarketresearch.com/market-analysis/auto-injectors-market

Key companies in the auto-injectors market is collaborating to offer advanced auto-injectors. In March 2017, Mylan N.V. entered in a global settlement and license agreement with Genentech Inc and Roche Holding AG in relation to patents for Herceptin (trastuzumab), which provides Mylan N.V. with global licenses for its trastuzumab product. This is expected to help Mylan N.V. to commercialize trastuzumab globally, except in Japan, Brazil and Mexico.

Some of the key players operating in the global auto-injectors market include Mylan N.V., Antares Pharma Inc., Becton, Dickinson & Co., Eli Lilly and Company, Pfizer, Inc., Bayer AG, Novartis International AG, Bristol-Myer Squibb, Novartis AG, Amgen Inc. and Biogen Inc.

Surgical Sealants and Adhesives Market – Global Industry Insights, Analysis, Growth, 2023

Surgical Sealants and Adhesives Market

The global surgical sealants and adhesive market is significantly growing, due to technological advancements, extensive research and development activities, and up surging academic and government research for medical devices. The massive unexplored market in the surgical sealants and adhesives industry of the developing economies is creating abundant growth opportunities for the surgical sealants and adhesives market.

Explore more or request TOC on Global Surgical Sealants and Adhesives Market at:

https://www.psmarketresearch.com/market-analysis/surgical-sealants-and-adhesives-market

In addition, the advanced research and development facilities and innovative product developments by the companies are propelling the growth of the surgical sealants and adhesives market. The surgical adhesive and sealants are alternative for traditional closure techniques, such as sutures, wires and staples. The conventional closure techniques may lead to further tissue trauma, risk of infection and is difficult to use at some surgical locations. Surgical sealant are likely to replace sutures and staples, as they have better closure abilities, faster implementation and facilitate less painful operation.

On the basis of product, the global surgical sealants and adhesives market can be categorized as natural or biological sealants and adhesive, and synthetic and semi synthetic adhesive and sealants, where natural or biological sealants and adhesives segment leads the global market in terms of market size. Natural or biological sealants and adhesives are further segmented on the basis of type, as fibrin sealants, collagen based adhesives and gelatin based adhesives, where fibrin sealant leads the  global segmented market in terms of market size.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/surgical-sealants-and-adhesives-market/report-sample

Some of the companies operating in the global surgical sealants and adhesives market are Baxter International Inc., Sanofi Group, B. Braun Melsungen AG, Ocular Therapeutix Inc., Cryolife Inc., Medtronic PLC, Johnson & Johnson, C.R. Bard Inc., Cohera Medical Inc. and Vivostat A/S.

Tumor Ablation Market Size, Analysis, Drivers, Trends, Challenges & Forecast, 2023

Tumor Ablation MarketThe global tumor ablation market is growing considerably, due to increasing awareness of ablation procedure over other surgical and conventional procedures, and increasing demand for minimally invasive cancer treatment procedure. The increasing investment in research and development to introduce novel therapies, such as chemo therapy and radiation therapy, are creating opportunities for the global tumor ablation market.

Explore more or request TOC on “Global Tumor Ablation Market” at: https://www.psmarketresearch.com/market-analysis/tumor-ablation-market

In addition, the massive unexplored market in the tumor ablation industry of the developing economies is creating abundant opportunities for the global tumor ablation market, to grow at a considerable rate during the forecast period. The increasing adoption rate of radio frequency based tumor ablation procedure is a trend, witnessed in the global tumor ablation market.

On the basis of technology, the global tumor ablation market can be categorized as cryoablation, radio frequency ablation, microwave ablation and others. The radio frequency ablation leads the global tumor ablation market in terms of market size, due to its specification of treating target tissues without causing significant damage to the surrounding healthy cells. Whereas, microwave ablation technology is expected to grow at the fastest rate in the coming years, due to increasing private funding and increasing adoption of microwave tumor ablation among healthcare professionals.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/tumor-ablation-market/report-sample

Geographically, North America is likely to dominate the global tumor ablation market in the coming years, due to high adoption of tumor ablation products and increasing demand for minimally invasive surgeries. However, the ongoing healthcare reforms in the U.S. are inhibiting the growth of North America tumor ablation market. Asia-Pacific is the fastest growing region in the global tumor ablation market, due to presence of huge pool of patients, intensifying government support, and increasing prevalence of cancer in the region. In addition, the tumor ablation Asia-Pacific market is growing, due to increasing healthcare expenditure and refining healthcare infrastructure in the emerging countries, such as India and China.

Some of the companies operating in the global tumor ablation market are Mermaid Medical A/S, Medtronic PLC, Boston Scientific Corporation, HealthTronics Inc., CONMED Corporation, EDAP TMS S.A., AngioDynamics Inc., Galil Medical Inc., Misonix Inc., Neuwave Medical Inc., Smith & Nephew PLC and Sonacare Medical LLC.

Hemodynamic Monitoring Systems Market Size – Drivers, Restraints, Opportunities, and Challenges

Hemodynamic Monitoring Systems MarketThe global hemodynamic monitoring systems market is growing due to technological advancement in hemodynamic monitoring systems, such as minimally invasive and noninvasive technologies. The minimally invasive and noninvasive technologies are preferred, in order to reduce infection associated diseases, decrease pain, and increase comfort of the patient. The massive unexplored market in the hemodynamic monitoring systems industry of the developing economies is creating abundant opportunities for the growth of the global hemodynamic monitoring systems market.

Explore more or request TOC on “Global Hemodynamic Monitoring Systems Market” at: https://www.psmarketresearch.com/market-analysis/hemodynamic-monitoring-systems-market

Hemodynamic monitoring is the continuous movement of blood and pressure exerted in the veins, arteries, and heart. Hemodynamic monitoring systems are used to monitor oxygenation of tissue and organ, blood pressure, and cardiac output. It is also used to evaluate effectiveness of the cardiovascular function. These tests are performed to monitor loss of cardiac functions, such as cardiomyopathy, congestive heart failure and myocardial infarction, decreased urine output, decreased cardiac output, and gastrointestinal bleeding.

On the basis of type, the global hemodynamic patient monitoring systems market can be categorized as minimally invasive systems, invasive hemodynamic monitoring systems, and noninvasive systems. Invasive hemodynamic monitoring systems leads the global hemodynamic monitoring systems market in terms of market size, due to identification, early detection, and treatment of life threatening diseases; whereas, the market share minimally invasive hemodynamic monitoring systems is expected to grow at the fastest rate in the coming years. In addition, on the basis of end user, the global hemodynamic patient monitoring systems market can be categorized as hospitals, catheterization laboratories, and home and ambulatory sites. Hospitals lead the global hemodynamic monitoring systems market in terms of market size, and are expected to grow at the fastest rate in the coming years.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/hemodynamic-monitoring-systems-market/report-sample

Some of the companies operating in the global hemodynamic monitoring systems market are Edward Lifesciences Corporation, Pulsion Medical Systems Se, Cheetah Medical Inc., HEMO Sapiens Inc., Deltex Medical Group PLC, ICU Medical Inc., Tensys Medical Inc. Osypka Medical GMBH, Lidco Group PLC and Schwarzer Cardiotek GmbH.